Shares of MetLife, Inc. (NYSE:MET – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the twelve analysts that are presently covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a hold recommendation, nine have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 year target price among brokerages that have covered the stock in the last year is $94.60.
MET has been the topic of several research reports. UBS Group dropped their price objective on shares of MetLife from $96.00 to $95.00 and set a “buy” rating on the stock in a report on Thursday, November 6th. Wolfe Research raised MetLife to a “strong-buy” rating in a research report on Tuesday, September 16th. Cowen reaffirmed a “buy” rating on shares of MetLife in a report on Friday, August 22nd. Piper Sandler downgraded MetLife from an “overweight” rating to a “neutral” rating and set a $84.00 price objective for the company. in a research report on Friday, September 19th. Finally, Wells Fargo & Company lowered their price objective on MetLife from $96.00 to $92.00 and set an “overweight” rating on the stock in a research report on Friday, November 7th.
Get Our Latest Research Report on MetLife
Institutional Trading of MetLife
MetLife Stock Up 0.8%
MET opened at $76.95 on Monday. The business has a 50 day moving average of $79.02 and a 200-day moving average of $78.81. The stock has a market capitalization of $50.70 billion, a price-to-earnings ratio of 13.04, a P/E/G ratio of 0.70 and a beta of 0.87. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.57. MetLife has a 1-year low of $65.21 and a 1-year high of $88.68.
MetLife (NYSE:MET – Get Free Report) last released its earnings results on Wednesday, November 5th. The financial services provider reported $2.37 EPS for the quarter, beating the consensus estimate of $2.30 by $0.07. MetLife had a net margin of 5.83% and a return on equity of 19.88%. The firm had revenue of $12.46 billion during the quarter, compared to analysts’ expectations of $18.64 billion. During the same period in the prior year, the company earned $1.95 EPS. The business’s quarterly revenue was down 5.9% compared to the same quarter last year. As a group, sell-side analysts anticipate that MetLife will post 9.65 earnings per share for the current year.
MetLife Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 9th. Stockholders of record on Tuesday, November 4th will be paid a $0.5675 dividend. The ex-dividend date is Tuesday, November 4th. This represents a $2.27 dividend on an annualized basis and a dividend yield of 3.0%. MetLife’s dividend payout ratio is currently 42.75%.
MetLife Company Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Read More
- Five stocks we like better than MetLife
- Insider Buying Explained: What Investors Need to Know
- Power On: Applied Digital’s First AI Data Center Goes Live
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Alphabet: The AI Leader Best Positioned to Dominate 2026
- Should You Invest in Penny Stocks?
- 2 Reasons to Load Up on Fiserv, 1 to Stay Away
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.
